EP 3938365 A1 20220119 - COMPOSITIONS AND METHODS FOR TREATING ANDROGEN RECEPTOR POSITIVE FORMS OF CANCER
Title (en)
COMPOSITIONS AND METHODS FOR TREATING ANDROGEN RECEPTOR POSITIVE FORMS OF CANCER
Title (de)
ZUSAMMENSETZUNGEN UND VERFAHREN ZUR BEHANDLUNG VON ANDROGENREZEPTORPOSITIVEN FORMEN VON KREBS
Title (fr)
COMPOSITIONS ET PROCÉDÉS POUR TRAITER DES FORMES POSITIVES DE RÉCEPTEURS DES ANDROGÈNES DU CANCER
Publication
Application
Priority
- US 201962819476 P 20190315
- US 201962819482 P 20190315
- US 201962819487 P 20190315
- US 201962819472 P 20190315
- US 201962819490 P 20190315
- US 201962821660 P 20190321
- US 2019039936 W 20190628
- US 2020022823 W 20200313
Abstract (en)
[origin: WO2020190792A1] Pharmaceutical compositions comprising a CBP Inhibitor compound can be used to treat patients diagnosed with Androgen Receptor positive forms of cancer, such as mCRPC and TNBC, including patients diagnosed with the AR-v7 splice form.
IPC 8 full level
C07D 471/04 (2006.01); A61K 31/437 (2006.01); A61P 35/00 (2006.01)
CPC (source: EP)
A61K 31/4745 (2013.01); A61P 35/00 (2018.01); C07D 471/04 (2013.01)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2020190792 A1 20200924; AU 2020241709 A1 20210923; BR 112021018266 A2 20220201; CA 3132995 A1 20200924; CN 113784967 A 20211210; CN 113784967 B 20240726; EP 3938365 A1 20220119; EP 3938365 A4 20230125; MX 2021011154 A 20211022
DOCDB simple family (application)
US 2020022823 W 20200313; AU 2020241709 A 20200313; BR 112021018266 A 20200313; CA 3132995 A 20200313; CN 202080021617 A 20200313; EP 20774663 A 20200313; MX 2021011154 A 20200313